Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,221 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Study of MLN8237 in Combination With Irinotecan and Temozolomide

NCT01601535

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Children Hospital of Colorado Aurora, Colorado, United States
View all 13 locations
View Trial Details
Completed

Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab

NCT01515189

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • The Angeles Clinic And Research Institute Los Angeles, California, United States
  • University Of California Los Angeles Los Angeles, California, United States
  • Baptist Cancer Institute Jacksonville, Florida, United States
  • Orlando Health, Inc Orlando, Florida, United States
View all 88 locations
View Trial Details
Completed

A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors

NCT01525550

Conditions
Adenoma, Carcinoma, Digestive System Diseases, +14 more
Locations
  • Univeristy of California Orange, California, United States
  • Columbia University Medical Center New York, United States
  • Barwon Health - University Hospital Geelong Geelong, Victoria, Australia
  • Cliniques Universitaires Saint-Luc, Gastroenterologie Brussels, Brussels Gewest, Belgium
View all 26 locations
View Trial Details
Completed

A Study of Vemurafenib and GDC-0973 (Cobimetinib) in Participants With BRAFV600E Mutation-Positive Metastatic Melanoma

NCT01271803

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • UCLA Department of Medicine Los Angeles, California, United States
  • University of California at San Francisco San Francisco, California, United States
  • The Angeles Clinic and Research Institute, Santa Monica Office Santa Monica, California, United States
  • University of Colorado; Anschutz Cancer Pavilion Aurora, Colorado, United States
View Trial Details
Completed

Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

NCT00423735

Conditions
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +19 more
Locations
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Arizona Oncology Services Foundation Scottsdale, Arizona, United States
  • The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
  • Sutter Cancer Centers Radiation Oncology Services-Auburn Auburn, California, United States
View all 188 locations
View Trial Details
Completed

Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma

NCT00884741

Conditions
Astrocytoma, Glioblastoma, Glioma, +9 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Arizona Oncology Services Foundation Scottsdale, Arizona, United States
View all 330 locations
View Trial Details

Related conditions